Hernan A Bazan1, Samuel A Hatfield1, Chasity B O'Malley1, Ashton J Brooks1, Daniel Lightell1, T Cooper Woods2. 1. From the Section of Vascular and Endovascular Surgery, Department of Surgery (H.A.B., A.J.B.) and Laboratory of Molecular Cardiology (C.B.O.), Ochsner Clinic, New Orleans, LA; and Tulane Heart and Vascular Institute and the Department of Physiology, Tulane School of Medicine, New Orleans, LA (S.A.H., A.J.B., D.L., T.C.W.). 2. From the Section of Vascular and Endovascular Surgery, Department of Surgery (H.A.B., A.J.B.) and Laboratory of Molecular Cardiology (C.B.O.), Ochsner Clinic, New Orleans, LA; and Tulane Heart and Vascular Institute and the Department of Physiology, Tulane School of Medicine, New Orleans, LA (S.A.H., A.J.B., D.L., T.C.W.). Twoods3@tulane.edu.
Abstract
BACKGROUND AND PURPOSE: Atherosclerotic plaque vulnerability is accompanied by changes in the molecular and cellular function in the plaque shoulder, including a decrease in vascular smooth muscle cell proliferation. We aimed to determine whether the expression of 3 miRNAs that regulate vascular smooth muscle cell proliferation (miR-145, miR-221, and miR-222) is altered with plaque rupture, suggesting a role in regulating plaque stability. METHODS: miRNAs were measured in the plaque shoulder of carotid plaques obtained from patients undergoing carotid endarterectomy (CEA) for 3 distinct clinical scenarios: (1) patients without previous neurological events but high-grade carotid stenosis (asymptomatic), (2) patients with an acute neurological event within 5 days of the CEA (urgent), and (3) patients undergoing CEA>5 days after a neurological event (symptomatic). RESULTS: Mean time from plaque rupture event to CEA was 2.4 days in the urgent group. The urgent group exhibited a significant decrease in miR-221 and miR-222 expression in the plaque shoulder, whereas no significant differences were seen in miR-145 across the 3 groups. Regression analysis demonstrated a significant correlation between time from the neurological event to CEA and increasing miR-221 and miR-222, but not miR-145. mRNA encoding p27Kip1, a target of miR-221 and miR-222 that inhibits vascular smooth muscle cell proliferation, was increased in the urgent group. CONCLUSIONS: Atherosclerotic plaque rupture is accompanied by a loss of miR-221 and miR-222 and an increase in p27Kip1 mRNA expression in the plaque shoulder, suggesting an association between these miRNAs and atherosclerotic plaque stability.
BACKGROUND AND PURPOSE:Atherosclerotic plaque vulnerability is accompanied by changes in the molecular and cellular function in the plaque shoulder, including a decrease in vascular smooth muscle cell proliferation. We aimed to determine whether the expression of 3 miRNAs that regulate vascular smooth muscle cell proliferation (miR-145, miR-221, and miR-222) is altered with plaque rupture, suggesting a role in regulating plaque stability. METHODS: miRNAs were measured in the plaque shoulder of carotid plaques obtained from patients undergoing carotid endarterectomy (CEA) for 3 distinct clinical scenarios: (1) patients without previous neurological events but high-grade carotid stenosis (asymptomatic), (2) patients with an acute neurological event within 5 days of the CEA (urgent), and (3) patients undergoing CEA>5 days after a neurological event (symptomatic). RESULTS: Mean time from plaque rupture event to CEA was 2.4 days in the urgent group. The urgent group exhibited a significant decrease in miR-221 and miR-222 expression in the plaque shoulder, whereas no significant differences were seen in miR-145 across the 3 groups. Regression analysis demonstrated a significant correlation between time from the neurological event to CEA and increasing miR-221 and miR-222, but not miR-145. mRNA encoding p27Kip1, a target of miR-221 and miR-222 that inhibits vascular smooth muscle cell proliferation, was increased in the urgent group. CONCLUSIONS:Atherosclerotic plaque rupture is accompanied by a loss of miR-221 and miR-222 and an increase in p27Kip1 mRNA expression in the plaque shoulder, suggesting an association between these miRNAs and atherosclerotic plaque stability.
Authors: E R O'Brien; C E Alpers; D K Stewart; M Ferguson; N Tran; D Gordon; E P Benditt; T Hinohara; J B Simpson; S M Schwartz Journal: Circ Res Date: 1993-08 Impact factor: 17.367
Authors: Thomas Boettger; Nadine Beetz; Sawa Kostin; Johanna Schneider; Marcus Krüger; Lutz Hein; Thomas Braun Journal: J Clin Invest Date: 2009-08-17 Impact factor: 14.808
Authors: Chasity B Coleman; Daniel J Lightell; Stephanie C Moss; Michael Bates; Patrick E Parrino; T Cooper Woods Journal: Mol Cell Endocrinol Date: 2013-05-03 Impact factor: 4.102
Authors: Eduard Hergenreider; Susanne Heydt; Karine Tréguer; Thomas Boettger; Anton J G Horrevoets; Andreas M Zeiher; Margot P Scheffer; Achilleas S Frangakis; Xiaoke Yin; Manuel Mayr; Thomas Braun; Carmen Urbich; Reinier A Boon; Stefanie Dimmeler Journal: Nat Cell Biol Date: 2012-02-12 Impact factor: 28.824
Authors: Kimberly R Cordes; Neil T Sheehy; Mark P White; Emily C Berry; Sarah U Morton; Alecia N Muth; Ting-Hein Lee; Joseph M Miano; Kathryn N Ivey; Deepak Srivastava Journal: Nature Date: 2009-07-05 Impact factor: 49.962
Authors: Hernan A Bazan; Samuel A Hatfield; Aaron Brug; Ashton J Brooks; Daniel J Lightell; T Cooper Woods Journal: Circ Cardiovasc Genet Date: 2017-08
Authors: Hernan A Bazan; Yan Lu; Bokkyoo Jun; Zhide Fang; T Cooper Woods; Song Hong Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2017-08-26 Impact factor: 4.006